Immuneering Corporation (IMRX)
NASDAQ·Healthcare·Biotechnology
$5.28
+0.67%
Mkt Cap $209.10M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (6 analysts)
$21.00
Range $12.00 – $30.00
Implied Upside
+297.7%
Consensus $21.00 vs current $5.28
NASDAQ·Healthcare·Biotechnology
$5.28
+0.67%
Mkt Cap $209.10M
Buy
2
Hold
0
Sell
0
Price Target (6 analysts)
$21.00
Range $12.00 – $30.00
+297.7%
Consensus $21.00 vs current $5.28